Last updated on March 2019

Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients


Brief description of study

The objective of this post-marketing surveillance study is to observe the safety profile of Fycompa film-coated tablets 2/4/6/8/10/12 milligrams (mg) in a normal clinical practice setting.

Clinical Study Identifier: NCT02722590

Contact Investigators or Research Sites near you

Start Over

Youngji Pyo

Chungju, Korea, Republic of
  Connect »

Youngji Pyo

Wonju, Korea, Republic of
  Connect »

Youngji Pyo

Seongnam, Korea, Republic of
  Connect »

Youngji Pyo

Jinju, Korea, Republic of
  Connect »

Youngji Pyo

Gwangju, Korea, Republic of
  Connect »

Youngji Pyo

Busan, Korea, Republic of
  Connect »

Youngji Pyo

Daegu, Korea, Republic of
  Connect »

Youngji Pyo

Daejeon, Korea, Republic of
  Connect »

Youngji Pyo

Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.